The role and therapeutic potential of nanotechnology-mediated ferroptosis regulation in myelodysplastic syndromes - Top-Institutions - MDSpire

The role and therapeutic potential of nanotechnology-mediated ferroptosis regulation in myelodysplastic syndromes

By
Wanhua An
Shuli Guo
Haojie Wang
Tao Lv
Wanli Wang
Bo Li
Mengyu Liu
Pu Yang
Farra Aidah Jumuddin
July 1, 2026
0 min

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

The University of Texas MD Anderson Cancer Center

Houston, Texas
Key Differentiators
- Hematology
- Oncology
- Nanotechnology
#2

Memorial Sloan Kettering Cancer Center

New York, New York
Key Differentiators
- Hematology
- Oncology
- Nanotechnology
#3

Federal Technological University of Paraná

Londrina, Paraná
Key Differentiators
- Nanotechnology
- Pharmaceutical Sciences
#4

University Hospital Hamburg-Eppendorf

Hamburg, Germany
Key Differentiators
- Hematology
- Oncology
#5

University of Hamburg

Hamburg, Germany
Key Differentiators
- Hematology
- Oncology

Original Source(s)

Frontiers In Oncology

The role and therapeutic potential of nanotechnology-mediated ferroptosis regulation in myelodysplastic syndromes

by Wanhua An, Shuli Guo, Haojie Wang, Tao Lv, Wanli Wang, Bo Li, Mengyu Liu, Pu Yang, Farra Aidah Jumuddin
July 1, 2026

Related Content

Frontiers In Oncology

Multimodal imaging features of primary breast epithelial–myoepithelial carcinoma: a case report and literature review

Gut

Complement-secreting CAFs are associated with better prognosis in pancreatic cancer: single-cell multiomics

Frontiers In Surgery

Impact of RAS mutation status on early progression in patients with initially unresectable colorectal liver metastases undergoing conversion therapy: a retrospective analysis